Our previous studies have shown that relatively early-stage Alzheimer's disease (AD) patients have already endured a significant deterioration in the structure of their semantic knowledge. Given that AD is a progressive disease, the patients' semantic network should manifest a further deterioration by the later stages of their disease. To evaluate the nature and degree of this deterioration, the present study will use multidimensional scaling techniques (MDS) to compare the semantic networks of mildly (Mid-AD), moderately (Mod-AD) and severely (Sev-AD) demented AD patients. It is anticipated that the semantic networks of Mid-AD, Mod-AD and Sev-AD will be different in terms of the primary dimension of organization, the clustering of concepts and in the variance or heterogeneity of performances within each group. Understanding the semantic networks of AD patients in different stages of the disease is both theoretically and clinically significant. Given that AD results in severe pathological changes in the cortex, examining the semantic networks of AD patients will help in understanding the different neuronal pathways by which different components of semantic information are stored and distributed. On a clinical level, a thorough knowledge of the progressive changes in AD patient's semantic space could have importance for the early detection and accurate staging of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-13
Application #
5204438
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
González, Hector M; Tarraf, Wassim; Harrison, Kimystian et al. (2018) Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results. Alzheimers Dement 14:579-589
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Jurick, Sarah M; Weissberger, Gali H; Clark, Lindsay R et al. (2018) Faulty Adaptation to Repeated Face-Name Associative Pairs in Mild Cognitive Impairment is Predictive of Cognitive Decline. Arch Clin Neuropsychol 33:168-183
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124

Showing the most recent 10 out of 914 publications